J Korean Ophthalmol Soc.  2008 Oct;49(10):1685-1689.

Acellular Dermal Allograft Transplantation in Patients with Scleromalacia After Pterygium Excision

• Song HY
• Im JS
• Kwak JY

Abstract

PURPOSE
To report two cases of successful acellular dermal allograft transplantation for scleromalacia following pterygium excision.
CASE SUMMARY
A 72-year-old female patient developed scleromalacia on the nasal side of the right eye, and a 79-year-old female patient developed scleromalacia with inflammation on the nasal side of the left eye. They had previous histories of pterigia removal on the sites of scleromalacia. Acellular dermal allograft (AlloDerm(R), Lifecell, NJ, USA) transplantations were done. After the operations, inflammation and pain ameliorated and the grafts survived without any particular complications.
CONCLUSIONS
In treating scleromalacia, the transplantation of acellular dermal allografts produced relatively satisfactory results without undesirable problems commonly encountered when using conventional materials.

Keyword

AlloDerm(R); Scleromalacia

MeSH Terms

Aged
Eye
Female
Humans
Inflammation
Pterygium
Transplantation, Homologous
Transplants

Figure

• 

  Figure 1. (A) Five days after scleral reinforcement with acellular dermal allograft. (B) Three months after acellular dermal allograft transplantation, showing good vascularization and stable ocular surface

• 

  Figure 2. Preoperative photograph shows scleral necrosis with calcific plaque in the area of previous pterygium excision.

• 

  Figure 3. (A) Three days after scleral reinforcement with acellular dermal allograft. (B) One month after acellular dermal allograft transplantation with amniotic membrane transplantation, showing epithelial covering.

Reference

References

1. Hong SB, Oh SJ, Oh JH. The effects and complications of Mitomycin-C for prevention of recurrence after pterygium operation. J Korean Ophthalmol Soc. 1998; 39:2013–8.

2. Moriarty AP, Crawford GJ, Mcallister IL, Constable IJ. Severe corneosclera infection: a complication of beta irradiation sclera necrosis following pterygium excision. Arch Ophthalmol. 1993; 111:947–51.

3. Kwak JY, Chang HG. Autogenous temporalis fascia grafting and conjunctival flap transposition in scleromalacia after pterygium excision. J Korean Ophthalmol Soc. 2004; 45:180–6.

4. Na YS, Joo MJ, Kim JH. Results of scleral allografting on scleral necrosis following pterygium excision. J Korean Ophthalmol Soc. 2005; 46:402–9.

5. Kang HS, Kim IC. Repair of scleral ulcer with Bovine pericardium. J Korean Ophthalmol Soc. 2003; 44:296–302.

6. Lee CO, Jong SH, Lee JJ. Autologous simple conjunctival graft and conjunctiva / Tenon graft on focal scleromalacia. J Korean Ophthalmol Soc. 1997; 38:1737–41.

7. Jeoung JW, Yoon YM, Lee JL. . The effect of amniotic membrane transplantation on the treatment of necrotizing scleritis after pterygium excision. J Korean Ophthalmol Soc. 2004; 45:1981–9.

8. Koenig SB, Kaufmann HE. The treatment of necrotizing scleritis with an autogenous periosteal graft. Ophthalmic Surg. 1983; 14:1029–32.

9. Torchia RT, Dunn RE, Pease PJ. Fascia lata grafting in scleromalacia perforans. Am J Ophthalmol. 1968; 66:705–9.

10. Breslin CW, Katz JI, Kaufmann HE. Surgical management of necrotizing scleritis: sclera reinforcement with autogenous periosteum. Arch Ophthalmol. 1977; 95:2038–40.

11. Mauriello JA Jr, Fiore PM, Pokorny KS, Cinotti DJ. Use of split-thickness dermal graft in the surgical treatment of corneal and scleral defects. Am J Ophthalmol. 1998; 105:244–7.

12. Wainwright DJ. Use of an acellular allograft dermal matrix (AlloDerm) in the management of full-thickness burns. Burns. 1995; 21:243–8.

13. Wainwright DJ, Madden M, Luterman A. . Clinical evaluaton of an acellular allograft dermal matrix (AlloDerm) in full-thickness burns. J Burn Care Rehabil. 1996; 17:124–36.

14. Fowler EB, Francis PO, Goho C. Use of an acellular dermal matrix allograft for management of inadequate attached gingiva in young patient. Mil Med. 2003; 168:261–5.

15. Buinewicz B, Rosen B. Acellular cadaveric dermis (Alloderm): a new alternative for abdominal hernia repair. Ann Plast Surg. 2004; 52:188–94.

16. Fayad JN, Baino T, Parsier SC. Preliminary results with the useof Alloderm in chronic otitis media. Laryngoscope. 2003; 113:1228–30.

17. Avenavoli FM, Corelli R, Vittori I. Use of Alloderm for lip reaugumentation. Ann Plast Surg. 2002; 48:447–8.

18. Ji JY, Kim YD. Acellular dermal allograft for the correction of eyelid retraction. J Korean Ophthalmol Soc. 2005; 46:1–9.

19. Lee NY, Choi WC, Yang SW. Anophthalmic conjunctival sac reconstruction using acellular dermal allograft. J Korean Ophthalmol Soc. 2006; 47:703–8.

20. Oh DE, Kim YD. Reconstruction of contracted anophthalmic socket with acellular dermal allograft. J Korean Ophthalmol Soc. 2008; 49:377–83.

21. Yoon KC, Ji YS, Park YG. Management of exposed hydroxyapatite implant with acellular dermal allograft. J Korean Ophthalmol Soc. 2005; 46:927–32.

22. Na TY, Park JW. Treatment of exposed hydroxyapatite orbital implant using acellular dermal allograft. J Korean Ophthalmol Soc. 2005; 46:396–401.

23. Reagan BJ, Madden MR, Huo J. . Analysis of acellular and decellular allogenetic dermal grafts for the treatment of full-thickness wounds ina porcine model. J Trauma. 1997; 43:458–66.

24. Castor SA, To WC, Papay FA. Lip augmentation with AlloDerm acellular allogenic dermal graft and fat autograft : A comparison of with autologous fat injection alone. Aesth Plast Surg. 1999; 23:218–23.

25. Ji JY, Kim YD. Acellular dermal allograft for the correction of eyelid retraction. J Korean Ophthalmol Soc. 2005; 46:1–9.

26. Rubin PA, Fay AM, Remulla HD, Maus M. Ophthalmic plastic applications of acellular dermal graft. Ophthalmology. 1999; 106:2091–7.

27. Shorr N, Perry JD, Goldberg RA. . The safty and applications acellular human dermal allograft in ophthalmic plastic and reconstructive surgery: a preliminary report. Ophthal Plast Reconstr Surg. 2000; 16:223–30.